annual CAPEX:
$6.46M+$4.98M(+336.92%)Summary
- As of today (July 3, 2025), MDGL annual capital expenditures is $6.46 million, with the most recent change of +$4.98 million (+336.92%) on December 31, 2024.
- During the last 3 years, MDGL annual CAPEX has risen by +$6.25 million (+2991.87%).
- MDGL annual CAPEX is now at all-time high.
Performance
MDGL CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
N/ASummary
- MDGL quarterly capital expenditures is not available.
Performance
MDGL quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM CAPEX:
N/ASummary
- MDGL TTM capital expenditures is not available.
Performance
MDGL TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
MDGL CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +336.9% | - | - |
| 3 y3 years | +2991.9% | - | - |
| 5 y5 years | +3657.0% | - | - |
MDGL CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2991.9% | ||||
| 5 y | 5-year | at high | +3657.0% | ||||
| alltime | all time | at high | >+9999.0% |
MDGL CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $6.46M(+336.9%) | $195.00K(-75.0%) | $6.46M(-11.5%) |
| Sep 2024 | - | $779.00K(-84.8%) | $7.30M(+6.4%) |
| Jun 2024 | - | $5.13M(+1337.3%) | $6.86M(+281.1%) |
| Mar 2024 | - | $357.00K(-65.5%) | $1.80M(+21.8%) |
| Dec 2023 | $1.48M(+581.6%) | $1.04M(+205.6%) | $1.48M(+213.3%) |
| Sep 2023 | - | $339.00K(+391.3%) | $472.00K(+184.3%) |
| Jun 2023 | - | $69.00K(+97.1%) | $166.00K(-17.0%) |
| Mar 2023 | - | $35.00K(+20.7%) | $200.00K(-7.8%) |
| Dec 2022 | $217.00K(+3.8%) | $29.00K(-12.1%) | $217.00K(-27.9%) |
| Sep 2022 | - | $33.00K(-68.0%) | $301.00K(-5.3%) |
| Jun 2022 | - | $103.00K(+98.1%) | $318.00K(+46.5%) |
| Mar 2022 | - | $52.00K(-54.0%) | $217.00K(+3.8%) |
| Dec 2021 | $209.00K(-37.4%) | $113.00K(+126.0%) | $209.00K(+97.2%) |
| Sep 2021 | - | $50.00K(+2400.0%) | $106.00K(+79.7%) |
| Jun 2021 | - | $2000.00(-95.5%) | $59.00K(-7.8%) |
| Mar 2021 | - | $44.00K(+340.0%) | $64.00K(-80.8%) |
| Dec 2020 | $334.00K(+94.2%) | $10.00K(+233.3%) | $334.00K(-27.1%) |
| Sep 2020 | - | $3000.00(-57.1%) | $458.00K(+1.1%) |
| Jun 2020 | - | $7000.00(-97.8%) | $453.00K(+1.8%) |
| Mar 2020 | - | $314.00K(+134.3%) | $445.00K(+158.7%) |
| Dec 2019 | $172.00K(+681.8%) | $134.00K(-6800.0%) | $172.00K(+273.9%) |
| Sep 2019 | - | -$2000.00(+100.0%) | $46.00K(-24.6%) |
| Jun 2019 | - | -$1000.00(-102.4%) | $61.00K(-1.6%) |
| Mar 2019 | - | $41.00K(+412.5%) | $62.00K(+181.8%) |
| Dec 2018 | $22.00K(-82.4%) | $8000.00(-38.5%) | $22.00K(+57.1%) |
| Sep 2018 | - | $13.00K(>+9900.0%) | $14.00K(+1300.0%) |
| Jun 2018 | - | $0.00(-100.0%) | $1000.00(-99.2%) |
| Mar 2018 | - | $1000.00(>+9900.0%) | $124.00K(-0.8%) |
| Dec 2017 | $125.00K(+4066.7%) | $0.00(0.0%) | $125.00K(-1.6%) |
| Sep 2017 | - | $0.00(-100.0%) | $127.00K(-0.8%) |
| Jun 2017 | - | $123.00K(+6050.0%) | $128.00K(+2460.0%) |
| Mar 2017 | - | $2000.00(0.0%) | $5000.00(+66.7%) |
| Dec 2016 | $3000.00(-97.9%) | $2000.00(+100.0%) | $3000.00(+200.0%) |
| Sep 2016 | - | $1000.00(-103.7%) | $1000.00(-98.3%) |
| Sep 2015 | - | -$27.00K(-200.0%) | $59.00K(-52.0%) |
| Jun 2015 | - | $27.00K(-54.2%) | $123.00K(-14.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $144.00K(-81.3%) | $59.00K(+59.5%) | $144.00K(-13.8%) |
| Sep 2014 | - | $37.00K(+48.0%) | $167.00K(+14.4%) |
| Jun 2014 | - | $25.00K(+8.7%) | $146.00K(-71.7%) |
| Mar 2014 | - | $23.00K(-72.0%) | $516.00K(-32.9%) |
| Dec 2013 | $769.00K(+52.3%) | $82.00K(+412.5%) | $769.00K(-0.3%) |
| Sep 2013 | - | $16.00K(-95.9%) | $771.00K(-20.0%) |
| Jun 2013 | - | $395.00K(+43.1%) | $964.00K(+52.1%) |
| Mar 2013 | - | $276.00K(+228.6%) | $634.00K(+25.5%) |
| Dec 2012 | $505.00K(-26.8%) | $84.00K(-59.8%) | $505.00K(-37.1%) |
| Sep 2012 | - | $209.00K(+221.5%) | $803.00K(-6.3%) |
| Jun 2012 | - | $65.00K(-55.8%) | $857.00K(+3.6%) |
| Mar 2012 | - | $147.00K(-61.5%) | $827.00K(+19.9%) |
| Dec 2011 | $690.00K(+407.4%) | $382.00K(+45.2%) | $690.00K(+106.0%) |
| Sep 2011 | - | $263.00K(+651.4%) | $335.00K(+135.9%) |
| Jun 2011 | - | $35.00K(+250.0%) | $142.00K(-2.7%) |
| Mar 2011 | - | $10.00K(-63.0%) | $146.00K(+7.4%) |
| Dec 2010 | $136.00K(-70.0%) | $27.00K(-61.4%) | $136.00K(+177.6%) |
| Sep 2010 | - | $70.00K(+79.5%) | $49.00K(+390.0%) |
| Jun 2010 | - | $39.00K(-165.0%) | $10.00K(-97.8%) |
| Dec 2009 | $454.00K(-79.2%) | -$60.00K(-293.5%) | $454.00K(-64.1%) |
| Sep 2009 | - | $31.00K(-69.3%) | $1.26M(-24.6%) |
| Jun 2009 | - | $101.00K(-73.6%) | $1.68M(-22.8%) |
| Mar 2009 | - | $382.00K(-49.0%) | $2.17M(-0.6%) |
| Dec 2008 | $2.18M(-7.1%) | $749.00K(+68.7%) | $2.18M(-5.1%) |
| Sep 2008 | - | $444.00K(-25.5%) | $2.30M(-8.6%) |
| Jun 2008 | - | $596.00K(+50.9%) | $2.52M(+11.8%) |
| Mar 2008 | - | $395.00K(-54.4%) | $2.25M(-4.2%) |
| Dec 2007 | $2.35M(+48.7%) | $866.00K(+31.2%) | $2.35M(+58.4%) |
| Sep 2007 | - | $660.00K(+99.4%) | $1.48M(+80.1%) |
| Jun 2007 | - | $331.00K(-32.9%) | $824.00K(+67.1%) |
| Mar 2007 | - | $493.00K(-40.6%) | $493.00K(-40.6%) |
| Dec 2006 | $1.58M(-67.6%) | - | - |
| Dec 2005 | $4.88M(+206.3%) | - | - |
| Mar 2005 | - | $830.00K | $830.00K |
| Dec 2004 | $1.59M(+107.3%) | - | - |
| Dec 2003 | $769.00K | - | - |
FAQ
- What is Madrigal Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Madrigal Pharmaceuticals?
- What is the all time high TTM CAPEX for Madrigal Pharmaceuticals?
What is Madrigal Pharmaceuticals annual capital expenditures?
The current annual CAPEX of MDGL is $6.46M
What is the all time high annual CAPEX for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual capital expenditures is $6.46M
What is Madrigal Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, MDGL annual capital expenditures has changed by +$4.98M (+336.92%)
What is the all time high quarterly CAPEX for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly capital expenditures is $5.13M
What is the all time high TTM CAPEX for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM capital expenditures is $7.30M